Explore answers to common questions about the FreeStyle Libre 2 system, its apps and software. Questions are organized by categories to help you easily find the information you’re looking for.
Explore answers to common questions about the FreeStyle Libre 2 system, its apps and software. Questions are organized by categories to help you easily find the information you’re looking for.
The FreeStyle Libre 2 system is indicated for people aged 4 and older living with diabetes. It includes real-time, optional glucose alarms for those who want or need them, including those with type 2 diabetes.
The FreeStyle Libre 2 system has all of the FreeStyle Libre system’s features, with the addition of optional, real-time glucose alarms. There are three optional, real-time glucose alarms that are available through the FreeStyle Libre 2 phone app.‡‡ There is a Low Glucose Alarm, High Glucose Alarm and Signal Loss Alarm.
The FreeStyle Libre 2 system is indicated for pediatric use in children aged 4 and up.
The FreeStyle Libre 2 system is priced the same as the FreeStyle Libre system.
Public coverage is currently available for the FreeStyle Libre system in Ontario,* Quebec,§§ the Yukon¶¶ and Prince Edward Island*** for eligible patients.
Public coverage is currently available for the FreeStyle Libre 2 system in Ontario,* Manitoba,§ Saskatchewan,‡ Quebec† and Prince Edward Island¶ for eligible patients. Abbott is in the process of seeking public and further private reimbursement for the FreeStyle Libre 2 system across Canada.
Most private health insurance companies cover the FreeStyle Libre 2 system. If you have private insurance, please speak to your plan administrator to find out how you may be covered.
If you have tried to fill your prescription at a pharmacy or spoken with your insurer and/or plan administrator and are still having difficulty determining if the FreeStyle Libre 2 system is covered or why you are not covered, please click here to register to receive more information regarding your coverage.
No, FreeStyle Libre 2 system sensors and the FreeStyle Libre 2 app‡‡ are NOT compatible with FreeStyle Libre system sensors, readers or the FreeStyle LibreLink app.††† It is critical that you use the matching sensors and app to ensure product functionality. The new FreeStyle Libre 2 app ‡‡ is available through the App Store or Google Play.
Yes, the FreeStyle Libre 2 system has a brand-new app.‡‡ The FreeStyle Libre 2 app‡‡ lets users easily share their glucose data with their healthcare providers** and caregivers.†† The new FreeStyle Libre 2 app‡‡ is available through the App Store or Google Play.
When in range, the FreeStyle Libre 2 system automatically communicates to give you Low and High Glucose Alarms if they are turned on. The Low Glucose Alarm notifies you if your glucose drops below the level you set. The High Glucose Alarm notifies you if your glucose rises above the level you set. The alarms do not include your glucose reading, so you need to scan your sensor to check your glucose reading.
To start a FreeStyle Libre 2 sensor with the FreeStyle Libre 2 app,‡‡ Bluetooth should be turned on. To receive alarms on your phone, your FreeStyle Libre 2 app‡‡ must be open or running in the background, your phone and sensor must be connected by Bluetooth, and phone Notifications must be enabled.
The FreeStyle Libre 2 system offers improved accuracy1 and no routine confirmatory finger pricks required for treatment decisions, even when glucose is low, falling or rapidly changing.‡‡‡
No, the FreeStyle Libre 2 system does not currently communicate with an insulin pump. However, as with any new technology, Abbott is researching a wide variety of potential applications.
Our FreeStyle Libre 2 digital ecosystem provides you with the FreeStyle Libre 2 mobile phone app‡‡ and LibreView,** a secure, cloud-based software that allows both you and your doctor to connect remotely at no cost.
To see how to download the FreeStyle Libre 2 app,‡‡ create a LibreView** account and set up data sharing with your doctor, visit the FreeStyle Libre 2 app‡‡ section of this website and watch the Sharing Glucose Readings video.
While LibreView*** is the best way to connect with your physician, you can also directly connect with your doctor using the FreeStyle Libre 2 app** via text or email.
In addition, remember that by using the LibreLinkUp app,†† you can invite your family/caregiver to also access your glucose data remotely, anytime. Visit the LibreLinkUp app†† section of this website to see how to do this.
Since September 16, 2019, the FreeStyle Libre system has been reimbursed by the Ontario Drug Benefit (ODB) program for qualifying Ontario residents who manage their diabetes with insulin.
The coverage will include both the FreeStyle Libre system sensors and reader.
If you qualify for ODB and you manage your diabetes with insulin, you are eligible for public reimbursement of the FreeStyle Libre system. Please speak with your healthcare professional (including your pharmacist) to determine if the FreeStyle Libre system is right for you.
More information about who is covered by the ODB program is available on the Ontario Drug Benefit website.
The FreeStyle Libre 2 flash glucose monitoring system is now reimbursed under the Régie de l’assurance maladie du Québec (RAMQ)§§§ prescription drug insurance plan for the following people in Quebec:
Those under the age of 18 and living with type 1 diabetes
Those over the age of 18, living with diabetes and who meet the following criteria:
On intensive insulin therapy (insulin pump treatment or ≥3 insulin injections per day)
Frequent hypoglycemic events during the last year, despite adherence to a blood sugar management plan
See the RAMQ Continuous and Flash Glucose Monitoring criteria here (PDF 5.7 MB).
Get a RAMQ Continuous and Flash Glucose Monitoring request form here.
The coverage will include the FreeStyle Libre 2 flash glucose monitoring system sensor, which can be paired up with the free FreeStyle Libre 2 app.‡‡
Since August 17, 2022, the FreeStyle Libre 2 flash glucose monitoring system has been reimbursed under Quebec’s prescription drug insurance plan for the following people in Quebec:
Please see the RAMQ List of Medications (PDF 5.7 MB) for more information.
Since June 1, 2021, the FreeStyle Libre 2 flash glucose monitoring system has been covered under the Saskatchewan government-sponsored drug plan for those between the ages of 4 and 17 who manage their diabetes with insulin or have hyperinsulinism.
The coverage will include both the FreeStyle Libre 2 flash glucose monitoring system sensors and the FreeStyle Libre 2 reader.
Since June 1, 2021, the FreeStyle Libre 2 flash glucose monitoring system has been covered under the Saskatchewan government-sponsored drug plan for those between the ages of 4 and 17 who manage their diabetes with insulin or have hyperinsulinism.
Please visit the Saskatchewan Drug Plan website or MyFreeStyle.ca for more information.
FreeStyle Libre 2 sensors are reimbursed under the Manitoba Pharmacare Program for individuals 25 years old and younger who meet eligibility criteria (PDF 488 kB).
Eligibility criteria are as follows:
Initial criteria:
For patients with type 1 diabetes who are 25 years of age or under and meet ALL of the following criteria:
1. Patient is either:
2. Under the care and management of a Manitoba endocrinologist, diabetes specialist or metabolic physician, and has routine follow-up with their diabetes care team.
3. Patient and/or caregiver demonstrates the capacity to use the CGM/FGM appropriately.
4. Patient and/or caregiver demonstrates a reasonable understanding of what the CGM/FGM can do and how it can benefit their care.
5. Patient and/or caregiver affirms a willingness to use the CGM/FGM properly and to use the data from this technology to make safe and effective diabetes management decisions.
Renewal criteria:
Coverage may be continued if ALL of the following are met:
Patient remains 25 years of age or under.
Patient remains under the care and management of an endocrinologist, diabetes specialist or metabolic physician, and has routine follow-up with their diabetes care team.
Patient and/or caregiver continues to demonstrate the capacity to use the CGM/FGM appropriately.
Patient and/or caregiver continues to demonstrate a reasonable understanding of what the CGM/FGM can do and how it can benefit their care.
Patient and/or caregiver continues to affirm a willingness to use the CGM/FGM properly and to use the data from this technology to make safe and effective diabetes management decisions.
Note: Coverage may also be discontinued upon notification from the care provider that the CGM/FGM criteria are no longer met by the patient.
Renewal Approval Duration: one year.
The Manitoba Pharmacare Program covers the FreeStyle Libre 2 sensors. Eligible Manitobans will be required to pay out-of-pocket for Freestyle Libre 2 sensors until their Pharmacare deductible has been met for the year, as they do for blood glucose test strips coverage.
The Manitoba Pharmacare Program covers the FreeStyle Libre 2 sensors. For eligible Manitobans who do not have a compatible mobile phone and require a FreeStyle Libre 2 reader, please contact Abbott Customer Care at 1-800-461-8481 (Monday-Friday: 8 AM-9 PM EST, Saturday: 9 AM-5 PM EST, Sunday: 9 AM-2 PM EST).
Coverage under the Manitoba Pharmacare Program became effective September 28, 2021.
Please visit the Manitoba Drug Benefits and Interchangeability Formulary website. See Pharmacare Information for Health Professionals | Health and Seniors Care | Province of Manitoba (gov.mb.ca) for more information.
FreeStyle Libre 2 sensors are reimbursed under the Manitoba Pharmacare Program for individuals 25 years old and younger who meet eligibility criteria (PDF 488 kB).
If you are currently using FreeStyle Libre, please speak to your healthcare professional for more information on the FreeStyle Libre 2 flash glucose monitoring system.
Since June 1, 2022, the FreeStyle Libre 2 flash glucose monitoring system has been reimbursed under the Prince Edward Island Pharmacare under their newly created provincial Diabetes Glucose Sensor Program. Those eligible must be 4 years of age or older, on multiple daily injections of insulin (three or more) or using an insulin pump, and must be enrolled in the Diabetes Glucose Sensor Program.
Enrolment in the Prince Edward Island Diabetes Glucose Sensor program began on May 18, 2022. Coverage has been effective since June 1, 2022. Details can be found online .
Coverage includes the FreeStyle Libre 2 flash glucose monitoring system sensors for those with diabetes who meet the criteria.
If you qualify for reimbursement for the FreeStyle Libre or FreeStyle Libre 2 flash glucose monitoring systems, you must submit by mail a completed PEI Glucose Sensor Program Initial Family Contribution Assessment and Release of Information form (PDF 356 kB) to the Glucose Sensor Program Administrator, Health PEI, 16 Garfield Street, Charlottetown, PE, C1A6A5. In subsequent years you can renew either online or via paper form.
The form can be downloaded and printed from the website or copies are available at local PEI Diabetes Education Centres.
Within this initial application form, there is a one-page Special Authorization document that requires completion by your medical practitioner, nurse practitioner or diabetes educator.
Please consult the Prince Edward Island (PEI) Provincial Diabetes Program website for additional details.
Please visit the Prince Edward Island (PEI) Provincial Diabetes Program website for additional details.
The app includes a series of reports that highlight your glucose trends and patterns. From the main menu, select the report you wish to see.
A minimum of 5 days of sensor data is required for an estimated A1C to be calculated.
You can email or text reports directly from the app by tapping the share icon that’s displayed at the bottom of each report available within the app. You can also show the reports on your phone to your doctor or nurse during your next appointment. LibreView** may also be an option if your doctor has set it up for patients to share data. See Data management and LibreView**
If you are receiving this error message, it means that you are not using a Canadian IP address. Try to download the software from another location or device that uses a Canadian IP. If you still experience issues, please contact an Abbott Customer Care Representative at 1-800-461-8481. Remember, we are here to help! We are available:
Monday-Friday: 8 AM-9 PM Eastern Standard Time
Saturday: 9 AM-5 PM Eastern Standard Time
Sunday: 9 AM-2 PM Eastern Standard Time
LibreView** is a cloud-based diabetes management system provided by Abbott and Newyu, Inc. LibreView** provides a secure repository for data from your FreeStyle Libre 2 app,‡‡ and allows you to easily share your glucose data with your healthcare professional or others, if you wish. Data is automatically¶¶¶ uploaded to LibreView** when your phone is connected to the internet.
LibreView** is used to manage your account information; it enables detailed reporting and data sharing. Once the app is installed and you accept the Terms of use, you will need to create a LibreView** account in order to start using the app. LibreView** allows you to share your glucose data with your healthcare professional and with other apps that connect with the FreeStyle Libre 2 app.‡‡
The app stores your account information, glucose data, notes and sensor information within the app on your phone, so it is your responsibility to limit access to your phone to protect personal information. The app also automatically uploads‡ this data in LibreView**, a secure cloud-based data repository. Please see our Privacy policy for more information.
Abbott and its partners comply with all applicable data protection and privacy laws in users’ jurisdictions. Please read the End User License Agreement and Terms of use or the Privacy policy within the app or visit LibreView** to ensure that you are comfortable with the data-handling practices that govern the use of the app and LibreView** ; otherwise, you should not install the app.
If you lose your phone, download the app again on a compatible phone and sign in with your account information. If you have an active sensor, reinstall the app and sign into your existing account. You’ll be able to continue using your active sensor until the end of its useful life. You will not be able to view historical data in the new installation of the app, but this data will be available in LibreView.**
No. Your glucose data from the FreeStyle Libre 2 app‡‡ will not be synced with FreeStyle Libre desktop software. The FreeStyle Libre 2 app‡‡ data is only stored by and visible through LibreView.**
Yes, with your permission, the app is able to share glucose data with certain other apps. View the “Share” menu within the FreeStyle LibreLink mobile app‡‡ to see what other apps are available for sharing in your region.
If you have any questions about the app‡‡ or your data, including questions on how to close your LibreView** account, contact us.
LibreLinkUp†† is a companion app to the FreeStyle Libre 2 app,‡‡ which allows glucose readings to be automatically¶¶¶ shared with your caregivers in near-real time.†† Both you and your caregivers must have a network connection to share and receive glucose readings.††
To add a LibreLinkUp†† connection through the FreeStyle Libre 2 app,‡‡ simply tap Share in the main menu and follow the onscreen instructions.
Every FreeStyle LibreLink scan is automatically sent to your phone, and up to 20 people can view results from a single FreeStyle LibreLink account.
You can get started with LibreLinkUp§ in 3 easy steps. Click here to learn how.
A1C is a measurement of your average glucose levels over the past three months. It’s used by healthcare professionals to measure how well your diabetes is being managed and is given as a percentage. The goal for most people with type 1 or type 2 diabetes is an A1C below 7%.2-4
The FreeStyle Libre system can give you actionable insights into your glucose trends and patterns. For example, it allows you to see how certain lifestyle factors, like food or exercise, are impacting your glucose levels. The actions you take based on these insights can help you better manage your diabetes and lower your A1C.
In fact, several studies have shown that people with type 1 and type 2 diabetes using the FreeStyle Libre flash glucose monitoring system were able to lower their A1C by 0.55%, on average.5****
* For people managing diabetes with insulin.
† To be eligible for FreeStyle Libre 2 reimbursement in Quebec, the criteria are as follows: under the age of 18 and living with type 1 diabetes; over the age of 18, living with diabetes and meets the following two criteria: is on intensive insulin therapy (insulin pump treatment or ≥3 insulin injections per day), and has frequent hypoglycemic events during the last year, despite adherence to a blood sugar management plan.
‡ The FreeStyle Libre 2 flash glucose monitoring system is covered under the Saskatchewan government-sponsored drug plan for those between the ages of 4 and 17 who manage their diabetes with insulin or have hyperinsulinism.
§ As of September 28, 2021, the FreeStyle Libre 2 flash glucose monitoring system is reimbursed under the Manitoba Pharmacare Program for individuals 25 years old and younger who meet eligibility criteria (PDF 488 kB) including a referral from a specialist.
¶ Those eligible for reimbursement in Prince Edward Island must be 4 years of age or older, be taking three or more daily injections of insulin or using an insulin pump, and must be enrolled in the Diabetes Glucose Sensor Program.
** The LibreView website is only compatible with certain operating systems and browsers. Please check www.libreview.com for additional information.
†† The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp and FreeStyle Libre 2 requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
‡‡ The FreeStyle Libre 2 app and the FreeStyle Libre 2 reader have similar but not identical features. Finger pricks are required if glucose readings and alarms do not match symptoms or expectations. The FreeStyle Libre 2 sensor communicates with the FreeStyle Libre 2 reader that started it or the FreeStyle Libre 2 app that started it. The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check the Compatibility Guide (PDF 69 kB) <Link to https://freestyleserver.com/Distribution/fxaa20.aspx?product=ifu_art39109_002&version=latest&os=all®ion=all&language=xx_yy> for more information about device compatibility before using the app. Use of FreeStyle Libre 2 requires registration with LibreView.
§§ For residents of Quebec, the following two criteria must be met: intensive insulin therapy (insulin pump treatment or ≥3 insulin injections per day), and frequent hypoglycemic events during the last year.
¶¶ For people over 18 years of age with type 1 diabetes.
*** Those eligible for reimbursement in Prince Edward Island must be 18 years of age or older, be taking three or more daily injections of insulin or using an insulin pump, and must be enrolled in the Diabetes Glucose Sensor Program.
††† The FreeStyle LibreLink app and the FreeStyle Libre reader have similar but not identical features. A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycemia or impending hypoglycemia is reported by the FreeStyle LibreLink app or when symptoms do not match the app readings. The FreeStyle Libre sensor communicates with the FreeStyle Libre reader that started it or the FreeStyle LibreLink app that started it. A sensor started by the FreeStyle Libre reader will also communicate with the FreeStyle LibreLink app. The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the Compatibiity Guide (PDF 69 KB) for more information about device compatibility before using the app. Use of FreeStyle LibreLink requires registration with LibreView.
‡‡‡ Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.
§§§ Official Mark of the Régie de l’assurance maladie du Québec.
¶¶¶ Use of FreeStyle LibreLink requires registration with LibreView. Automatic upload requires a wireless internet connection or mobile data connection.
**** Data from this study were collected with the FreeStyle Libre system. The FreeStyle Libre 2 system has the same features as the FreeStyle Libre system with optional real-time glucose alarms. Therefore, the study data are applicable to both products.
The FreeStyle Libre 2 flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people aged 4 years and older with diabetes mellitus. Always read and follow the label/insert.
The FreeStyle Libre flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in adults aged 18 years and older with diabetes mellitus. Always read and follow the label/insert.
You are now being redirected to a third-party website not under the control of Abbott. Abbott is not responsible for the contents of such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply the endorsement of the linked site by Abbott.
Do you wish to leave this site?
MyFreeStyle.ca is a product-specific website intended only for residents of Canada.
If you are a resident of another country, please visit our global directory to locate the appropriate site for your country.
